Exact Mass: 324.0255

Exact Mass Matches: 324.0255

Found 37 metabolites which its exact mass value is equals to given mass value 324.0255, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-O-(1-Carboxyvinyl)-3-phosphoshikimate

5-(1-carboxyethenoxy)-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid

C10H13O10P (324.0246)


   

Dorzolamide

(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulphonic acid amide

C10H16N2O4S3 (324.0272)


Dorzolamide is only found in individuals that have used or taken this drug. It is a carbonic anhydrase (CA) inhibitor. It is used in ophthalmic solutions (Trusopt) to lower intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension.Dorzolamide is a sulfonamide and a highly specific carbonic anhydrase II (CA-II) inhibitor, which is the main CA isoenzyme involved in aqueous humor secretion. Inhibition of CA-II in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Dorzolamide also accumulates in red blood cells as a result of CA-II binding, as CA-II is found predominantly in erythrocytes. However, sufficient CA-II activity remains so that adverse effects due to systemic CA inhibition are not observed. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EC - Carbonic anhydrase inhibitors D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor

   

Ethyl-4,4-dichlorobenzilate

Ethyl 2-hydroxy-2,2-bis(4-chlorophenyl)acetate

C16H14Cl2O3 (324.032)


   

1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea

N-(4-Chlorophenyl)-n-(4-methylbenzenesulphonyl)carbamimidic acid

C14H13ClN2O3S (324.0335)


   

Dulofibrate

4-Chlorophenyl 2-(4-chlorophenoxy)-2-methylpropanoic acid

C16H14Cl2O3 (324.032)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

2'-Deoxy-5'-O-thiophosphonouridine

{[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonothioic acid

C9H13N2O7PS (324.0181)


   
   

1-Propyl-1-[2-(2,4,6-trichlorophenoxy)ethyl]urea

Urea, N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-

C12H15Cl3N2O2 (324.0199)


   

(3R)-6-hydroxy-3-hydroxymethyl-2-methyl-2,3-dihydro-10H-3r,10ac-epidisulfano-pyrazino[1,2-a]indole-1,4-dione|Dehydrogliotoxin|Dehydroglyotoxin

(3R)-6-hydroxy-3-hydroxymethyl-2-methyl-2,3-dihydro-10H-3r,10ac-epidisulfano-pyrazino[1,2-a]indole-1,4-dione|Dehydrogliotoxin|Dehydroglyotoxin

C13H12N2O4S2 (324.0238)


   
   

PRZ_M325

Urea, N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-

C12H15Cl3N2O2 (324.0199)


CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2007

   

4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]benzaldehyde

4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]benzaldehyde

C16H14Cl2O3 (324.032)


   

4-(2,6-DICHLORO-BENZYLOXY)-3-ETHOXY-BENZALDEHYDE

4-(2,6-DICHLORO-BENZYLOXY)-3-ETHOXY-BENZALDEHYDE

C16H14Cl2O3 (324.032)


   

Boc-dap(bromoacetyl)-oh

Boc-dap(bromoacetyl)-oh

C10H17BrN2O5 (324.0321)


   

diethoxy-(4-methylsulfonylphenoxy)-sulfanylidene-λ5-phosphane

diethoxy-(4-methylsulfonylphenoxy)-sulfanylidene-λ5-phosphane

C11H17O5PS2 (324.0255)


   

N,N-Thiodiphthalimide

N,N-Thiodiphthalimide

C16H8N2O4S (324.0205)


   

trans-6-Methyl-4-ethylamino-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide

trans-6-Methyl-4-ethylamino-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide

C10H16N2O4S3 (324.0272)


   

3-[(4-CHLOROPHENYL)SULFONYL]METHYL-N-HYDROXYBENZENECARBOXIMIDAMIDE

3-[(4-CHLOROPHENYL)SULFONYL]METHYL-N-HYDROXYBENZENECARBOXIMIDAMIDE

C14H13ClN2O3S (324.0335)


   

5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yltrifluoromethanesulfonate

5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yltrifluoromethanesulfonate

C11H8F4N2O3S (324.0192)


   

N-Succinimidyl 4-(Azidosulfonyl)benzoate

N-Succinimidyl 4-(Azidosulfonyl)benzoate

C11H8N4O6S (324.0165)


   

2-(4-CHLOROSULPHONYLPHENYL)ETHYLTRIMETHOXYSILANE50 IN METHYLENE CHLORIDE

2-(4-CHLOROSULPHONYLPHENYL)ETHYLTRIMETHOXYSILANE50 IN METHYLENE CHLORIDE

C11H17ClO5SSi (324.0254)


   

2-(TRIFLUOROMETHYL)-5-[4-(TRIFLUOROMETHYL)PHENYL]-3-FUROIC ACID

2-(TRIFLUOROMETHYL)-5-[4-(TRIFLUOROMETHYL)PHENYL]-3-FUROIC ACID

C13H6F6O3 (324.0221)


   

1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea

1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea

C14H13ClN2O3S (324.0335)


   

2-(2-bromophenyl)-2,3-dihydro-1H-perimidine

2-(2-bromophenyl)-2,3-dihydro-1H-perimidine

C17H13BrN2 (324.0262)


   

N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide

N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide

C11H8N4O6S (324.0165)


   

2-Deoxy-5-fluoro-uridine 5-monophosphate

2-Deoxy-5-fluoro-uridine 5-monophosphate

C9H10FN2O8P-2 (324.0159)


   

1-[5-(Dihydroxyphosphinothioyloxymethyl)-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione

1-[5-(Dihydroxyphosphinothioyloxymethyl)-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione

C9H13N2O7PS (324.0181)


   

1-(3,4-Dichlorophenyl)-3-(3,5-dimethylphenyl)thiourea

1-(3,4-Dichlorophenyl)-3-(3,5-dimethylphenyl)thiourea

C15H14Cl2N2S (324.0255)


   

1-(2-Bromo-1-(trifluoromethoxy)ethyl)-4-(tert-butyl)benzene

1-(2-Bromo-1-(trifluoromethoxy)ethyl)-4-(tert-butyl)benzene

C13H16BrF3O (324.0337)


   

[4-[3-(3,5-Dihydroxyphenyl)oxiran-2-yl]phenyl] hydrogen sulate

[4-[3-(3,5-Dihydroxyphenyl)oxiran-2-yl]phenyl] hydrogen sulate

C14H12O7S (324.0304)


   

Dorzolamide

Dorzolamide

C10H16N2O4S3 (324.0272)


S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EC - Carbonic anhydrase inhibitors D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor

   

5-O-(1-carboxyvinyl)-3-phosphoshikimic acid

5-O-(1-carboxyvinyl)-3-phosphoshikimic acid

C10H13O10P (324.0246)


   

Iperoxo

Iperoxo

C10H17IN2O2 (324.0335)


Iperoxo is a potent superagonist of muscarinic acetylcholine receptor (mAChR). [3H]Iperoxo can be used for direct probing activation-related conformational transitions of muscarinic receptors[1][2]. Iperoxo is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   
   

7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

C13H12N2O4S2 (324.0238)


   

(3r,4s,5r)-5-[(1-carboxyeth-1-en-1-yl)oxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylic acid

(3r,4s,5r)-5-[(1-carboxyeth-1-en-1-yl)oxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylic acid

C10H13O10P (324.0246)


   

3,8-dichloro-11h,12h-indolo[2,3-a]carbazole

3,8-dichloro-11h,12h-indolo[2,3-a]carbazole

C18H10Cl2N2 (324.0221)